Range Low Price High Price Comment
30 days $1.71 $3.40 Tuesday, 30th Apr 2024 ESPR stock ended at $1.97. This is 1.01% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $1.94 to a day high of $2.04.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Feb 02, 2016 $15.60 $15.96 $14.48 $14.59 600 100
Feb 01, 2016 $14.79 $16.26 $14.45 $16.05 454 700
Jan 29, 2016 $14.23 $15.15 $13.88 $14.88 516 100
Jan 28, 2016 $15.01 $15.15 $13.89 $13.91 332 800
Jan 27, 2016 $16.26 $16.55 $14.32 $14.66 562 800
Jan 26, 2016 $16.58 $16.80 $15.36 $16.39 366 200
Jan 25, 2016 $18.16 $19.44 $16.53 $16.62 835 600
Jan 22, 2016 $17.65 $18.97 $17.25 $18.79 711 600
Jan 21, 2016 $15.64 $18.85 $15.23 $17.17 1 166 600
Jan 20, 2016 $12.94 $16.32 $12.61 $15.68 1 142 900
Jan 19, 2016 $14.31 $15.15 $13.42 $13.51 965 200
Jan 15, 2016 $14.56 $14.72 $13.50 $13.77 695 300
Jan 14, 2016 $14.12 $15.86 $13.11 $15.40 1 116 800
Jan 13, 2016 $16.75 $17.09 $14.10 $14.11 1 092 500
Jan 12, 2016 $16.58 $17.63 $15.50 $16.48 601 300
Jan 11, 2016 $18.15 $18.21 $15.80 $16.34 941 300
Jan 08, 2016 $18.26 $18.89 $17.67 $18.04 501 600
Jan 07, 2016 $19.14 $19.64 $17.66 $18.15 756 300
Jan 06, 2016 $21.63 $21.91 $19.63 $20.26 564 200
Jan 05, 2016 $21.80 $22.43 $21.47 $22.07 456 400
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT